Recently diagnosed with HIV? Click here

HIV treatments database

NAPWA's HIV treatments database contains summary information about HIV treatments in use and selected drugs under development. Information in this section of the website is general in nature and is intended to support, not replace, the advice you get from your treating doctor.

Generic namesort iconBrand nameClassStatus
abacavir Ziagennucleoside analogueS100 approved
abacavir + lamivudineKivexadouble NRTIS100 approved
abacavir + lamivudine + zidovudineTrizivirtriple NRTIS100 approved
apricitabinenucleoside analoguewithdrawn
atazanavirReyatazprotease inhibitorS100 approved
darunavirPrezistaprotease inhibitorS100 approved
delavirdineRescriptornon-nucleosideS100 approved
didanosineVidexnucleoside analogueS100 approved
efavirenzStocrinnon-nucleosideS100 approved
efavirenz + emtricitabine + tenofovirAtriplamulti-class formulationS100 approved
elvitegravirintegrase inhibitornot available on the PBS
emtricitabineEmtrivanucleoside analogueS100 approved
enfuvirtideFuzeonfusion inhibitorS100 approved
etravirineIntelencenon-nucleosideS100 approved
fosamprenavirTelzirprotease inhibitorS100 approved
GS-9350Cobicistatothernot available on the PBS
indinavirCrixivanprotease inhibitorS100 approved
lamivudineEpivirnucleoside analogueS100 approved
lamivudine + zidovudineCombivirdouble NRTIS100 approved
lopinavir + ritonavirKaletraprotease inhibitorS100 approved
maravirocCelsentriCCR5 antagonistS100 approved
nelfinavir Viraceptprotease inhibitorwithdrawn
nevirapineViramunenon-nucleosideS100 approved
raltegravirIsentressintegrase inhibitorS100 approved (restricted authority)
rilpivirinenon-nucleosidenot available on the PBS
ritonavirNorvirprotease inhibitorS100 approved
saquinavirInviraseprotease inhibitorS100 approved
stavudineZeritnucleoside analogueS100 approved
tenofovirVireadnucleotide analogueS100 approved
tenofovir + emtricitabineTruvadadouble NRTIS100 approved
tipranavirAptivusprotease inhibitorS100 approved
UK-453, 061non-nucleosidenot available on the PBS
zidovudineRetrovirnucleoside analogueS100 approved